QLTI:NGS-QLT Inc. (USD)

EQUITY | Others | Nasdaq Global Select

Last Closing

USD 23.2376

Change

+0.08 (+0.36)%

Market Cap

USD 0.10B

Volume

170.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.62 (-1.14%)

USD 53.00B
QQQM Invesco NASDAQ 100 ETF

-2.89 (-1.33%)

USD 38.88B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.39 (-0.67%)

USD 20.37B
ACWI iShares MSCI ACWI ETF

-0.91 (-0.76%)

USD 19.97B
CGABL The Carlyle Group Inc. 4.625% ..

-0.06 (-0.31%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-2.92 (-4.04%)

USD 5.35B
TSLL Direxion Shares ETF Trust - Di..

-3.48 (-9.92%)

USD 5.32B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 4.54B
ETHA iShares Ethereum Trust ETF

+0.05 (+0.20%)

USD 3.54B
USCL iShares Climate Conscious & Tr..

-0.82 (-1.14%)

USD 2.64B

ETFs Containing QLTI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.10B 15% F 7% C-

Key Financial Ratios

  Ratio vs. Industry/Classification (Others) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.